The class action suit filed by a US law firm against New York Stock Exchange-listed Dr Reddy's Laboratories Limited has only underlined the need for strengthening corporate governance practices by the management in the light of a series of regulatory set backs faced by the company in the recent past, according to some analysts.
They believe that the issues that led to the recent changes at the helm of Indian IT giant Infosys will keep returning to the big companies in one way or the other and it was high time for Dr Reddy's to stop thinking about taking mere incremental